195 related articles for article (PubMed ID: 28398414)
41. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
Dinger J; Bardenheuer K; Heinemann K
Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
[TBL] [Abstract][Full Text] [Related]
42. A single-center, randomized double-blind, parallel-group study to examine the safety and efficacy of 3mg drospirenone/0.02 mg ethinyl estradiol compared with placebo in the treatment of moderate truncal acne vulgaris.
Palli MB; Reyes-Habito CM; Lima XT; Kimball AB
J Drugs Dermatol; 2013 Jun; 12(6):633-7. PubMed ID: 23839178
[TBL] [Abstract][Full Text] [Related]
43. Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
Thorneycroft lH; Gollnick H; Schellschmidt I
Cutis; 2004 Aug; 74(2):123-30. PubMed ID: 15379365
[TBL] [Abstract][Full Text] [Related]
44. Oral Contraceptive Management in Aesthetic Surgery: A Survey of Current Practice Trends.
Chattha A; Brown E; Slavin S; Lin S
Aesthet Surg J; 2018 Feb; 38(3):NP56-NP60. PubMed ID: 29267904
[TBL] [Abstract][Full Text] [Related]
45. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
46. Real-life approach and treatment of chronic urticaria in Argentina: A National Survey.
Torre AC; Bollea Garlatti ML; Marciano S; Posadas-Martinez ML; Parisi CAS; Mazzuoccolo LD
Dermatol Ther; 2019 Nov; 32(6):e13086. PubMed ID: 31513726
[TBL] [Abstract][Full Text] [Related]
47. Contraception and the dermatologist.
Tyler KH; Zirwas MJ
J Am Acad Dermatol; 2013 Jun; 68(6):1022-9. PubMed ID: 23332517
[TBL] [Abstract][Full Text] [Related]
48. Yasmin: the reason why.
Thorneycroft IH
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():13-8; discussion 42-3. PubMed ID: 12659402
[TBL] [Abstract][Full Text] [Related]
49. Hormonal therapy for acne using oral contraceptive pills.
Harper JC
Semin Cutan Med Surg; 2005 Jun; 24(2):103-6. PubMed ID: 16092798
[TBL] [Abstract][Full Text] [Related]
50. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
[TBL] [Abstract][Full Text] [Related]
51. The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians.
Fadare JO; Adeoti AO; Desalu OO; Enwere OO; Makusidi AM; Ogunleye O; Sunmonu TA; Truter I; Akunne OO; Godman B
Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):639-650. PubMed ID: 26567041
[TBL] [Abstract][Full Text] [Related]
52. Treating acne with oral contraceptives: use of lower doses.
Huber J; Walch K
Contraception; 2006 Jan; 73(1):23-9. PubMed ID: 16371290
[TBL] [Abstract][Full Text] [Related]
53. Knowledge on adherence and safety of the oral contraceptive pill in Saudi women.
Al-Shaikh GK; Mayet AY; Alshaikh MK; Hamad AF; Mahmoud MA; Aljadhey HS
Saudi Med J; 2012 Jun; 33(6):665-70. PubMed ID: 22729123
[TBL] [Abstract][Full Text] [Related]
54. Economic stewardship in acne management.
Rosamilia LL
Cutis; 2018 Jul; 102(1):8-9. PubMed ID: 30138500
[No Abstract] [Full Text] [Related]
55. Depression and the dermatologist: a critical analysis of contemporary isotretinoin prescribing practices.
Daunton A; Oyebode F; Goulding JMR
Clin Exp Dermatol; 2019 Dec; 44(8):903-905. PubMed ID: 30912853
[TBL] [Abstract][Full Text] [Related]
56. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
57. Hormonal contraceptives for acne management.
Rich P
Cutis; 2008 Jan; 81(1 Suppl):13-8. PubMed ID: 18338653
[TBL] [Abstract][Full Text] [Related]
58. Real life management of chronic urticaria: Multicenter and cross sectional study on patients and dermatologists in Iran.
Firooz A; Akhlaghi A; Golbidi P; Pourjafari M; Abdollahimajd F; Azimi H; Banihashemi M; Darvish Damavandi F; Erfani AR; Farajzadeh S; Ghassemi M; Gheisari M; Hamedpour K; Handjani F; Hashemi SA; Herizchi H; Iraji F; Jalili H; Khatami A; Lajevardi V; Mansouri P; Masjedi H; Mehrian P; Mohammadi S; Mohebbi A; Namazi N; Nasiri Kashani M; Radmehr A; Safar F; Saffarian Z; Saneei S; Seirafi H; Taheri S; Yazdanpanah MJ; Zaboli Nejad N; Naseri M; Peiravi P; Teymori G
Dermatol Ther; 2019 Mar; 32(2):e12796. PubMed ID: 30520195
[TBL] [Abstract][Full Text] [Related]
59. Acne and oral contraceptives: update on women's health screening guidelines.
Frangos JE; Alavian CN; Kimball AB
J Am Acad Dermatol; 2008 May; 58(5):781-6. PubMed ID: 18359534
[TBL] [Abstract][Full Text] [Related]
60. Oral contraceptive switching patterns in the United Kingdom: an important potential confounding variable in studies of venous thromboembolism.
Farmer RD; Lawrenson RA; Hambleton IR
Eur J Contracept Reprod Health Care; 1996; 1(1):31-7. PubMed ID: 9678135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
